NEW YORK, Oct. 31, 2025 /PRNewswire/ — Metsera, Inc. (NASDAQ: MTSR) (“Metsera” or the “Company”) today issued the following statement in response to litigation filed against the Company by Pfizer: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback